Takip et
Gabriel V. Lupu, MD
Gabriel V. Lupu, MD
unchealth.unc.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Risk factors for colorectal polyps and cancer
JA Sninsky, BM Shore, GV Lupu, SD Crockett
Gastrointestinal Endoscopy Clinics of North America 32 (2), 195-213, 2022
1412022
Systematic review and meta-analysis on the effects of lactulose and rifaximin on patient-reported outcomes in hepatic encephalopathy
AM Moon, HP Kim, Y Jiang, G Lupu, JS Bissram, AS Barritt IV, EB Tapper
Official journal of the American College of Gastroenterology| ACG 118 (2 …, 2023
222023
Vancomycin is effective in the treatment of chronic inflammatory conditions of the pouch
G Lupu, KN Weaver, HH Herfarth, EL Barnes
Inflammatory bowel diseases 28 (10), 1610-1613, 2022
92022
Prevalent loss of BRCA1 and BRCA2 expression in African TNBC suggests their prominent role in sporadic carcinogenesis
EM Jiagge, S Wong, G Lupu, M Qiao, M Dziubinski, LA Newman, ...
Cancer Research 75 (15_Supplement), 3852-3852, 2015
32015
Oligometastatic Hepatocellular Carcinoma to the Perirectal Pelvis, a Rare Site of Distant Spread
GV Lupu, AS Barritt IV, AC Iuga, AM Moon, HK Sanoff, TK Yanagihara, ...
ACG Case Reports Journal 12 (2), e01615, 2025
2025
EMERGENCY DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN SEER-MEDICARE BENEFICIARIES: DISPARITIES AND UNDERTREATMENT
E Green, A Moon, S Lyon, G Lupu, Y He, SP Hinton, C Thompson
HEPATOLOGY 80, 2024
2024
TRENDS IN HCC DEATHS AND CONTRIBUTING CHRONIC LIVER DISEASE ETIOLOGIES-A CONTEMPORARY ANALYSIS OF NATIONAL DEATH CERTIFICATE DATA
A Moon, S Deutsch-Link, E Green, G Lupu, H Sanoff, T Yanagihara, ...
HEPATOLOGY 80, 2024
2024
S1973 Disparities in Locoregional Therapy Type or Curative Intent for Hepatocellular Carcinoma by Race or Ethnicity
S Power, Y Jiang, C Iloabachie, A Juneja, M Lund, G Lupu, J Badal, ...
Official journal of the American College of Gastroenterology| ACG 119 (10S …, 2024
2024
S1941 Mortality of Locoregional Therapy Outcomes for Hepatocellular Cancer Patients With Advanced HCC Stage Based on Performance Status
A Juneja, M Lund, Y Jiang, C Iloabachie, S Power, G Lupu, J Badal, ...
Official journal of the American College of Gastroenterology| ACG 119 (10S …, 2024
2024
S1991 Associations Between Liver Disease Etiology and Post-Liver Directed Treatment Mortality in HCC
C Iloabachie, Y Jiang, S Power, A Juneja, M Lund, G Lupu, J Badal, ...
Official journal of the American College of Gastroenterology| ACG 119 (10S …, 2024
2024
SAT-498 Patterns and predictors of acute care utilization after liverdirected therapy for hepatocellular carcinoma
A Moon, C Iloabachie, S Power, G Lupu, J Badal, Y Jiang, D Seligson, ...
Journal of Hepatology 80, S403, 2024
2024
Tu1585 PERCEPTIONS OF HCC TREATMENT GOALS AND PATIENT PREFERENCES BY PROVIDER SPECIALTY
GV Lupu, AS Barritt, DR Richardson, HK Sanoff, DM Mauro, ND Shah, ...
Gastroenterology 166 (5), S-1740, 2024
2024
LACTULOSE IMPROVES MULTIPLE QUALITY OF LIFE DOMAINS AMONG PATIENTS WITH HEPATIC ENCEPHALOPATHY: A META-ANALYSIS
G Lupu, HP Kim, JS Walker, SS Barritt IV, EB Tapper, A Moon
HEPATOLOGY 76, S1181-S1182, 2022
2022
614 VANCOMYCIN IS EFFECTIVE IN THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE POUCH
G Lupu, KN Weaver, HH Herfarth, EL Barnes
Gastroenterology 160 (6), S-122, 2021
2021
Vascular malformations masquerading as demyelinating disease
G Lupu, JF Cahill, SA Rizvi
Multiple Sclerosis and Related Disorders 38, 2020
2020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–15